Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

MLA

Pfeffer, M. A., et al. “Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and Design.” American Heart Journal, vol. 140, no. 5, Nov. 2000, pp. 727–50. EBSCOhost, https://doi.org/10.1067/mhj.2000.108832.

APA

Pfeffer, M. A., McMurray, J., Leizorovicz, A., Maggioni, A. P., Rouleau, J. L., Van De Werf, F., Henis, M., Neuhart, E., Gallo, P., Edwards, S., Sellers, M. A., Velazquez, E., & Califf, R. (2000). Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. American Heart Journal, 140(5), 727–750. https://doi.org/10.1067/mhj.2000.108832

Chicago

Pfeffer, M A, J McMurray, A Leizorovicz, A P Maggioni, J L Rouleau, F Van De Werf, M Henis, et al. 2000. “Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and Design.” American Heart Journal 140 (5): 727–50. doi:10.1067/mhj.2000.108832.